Last update 20 Mar 2025

Amprenavir/ritonavir

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target-
Action-
Mechanism-
Active Indication-
Inactive Indication
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhasePendingPhase 2/3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC25H35N3O6S
InChIKeyYMARZQAQMVYCKC-OEMFJLHTSA-N
CAS Registry161814-49-9
View All Structures (2)

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HIV InfectionsPhase 3
Spain
01 Apr 2001
HIV InfectionsPhase 3
United Kingdom
01 Apr 2001
HIV InfectionsPhase 3
Brazil
01 Apr 2001
HIV InfectionsPhase 3
Argentina
01 Apr 2001
HIV InfectionsPhase 3
Canada
01 Apr 2001
HIV InfectionsPhase 3
Italy
01 Apr 2001
HIV InfectionsPhase 3
United States
01 Apr 2001
HIV InfectionsPhase 3
Puerto Rico
01 Apr 2001
HIV InfectionsPhase 3
Poland
01 Apr 2001
HIV InfectionsPhase 3
France
01 Apr 2001
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
66
(wiwrgiksue) = hkfwygozpx jwumcbolod (bbenfryoza )
-
01 Jan 2004
(dpfmndbrxa) = wnibhwuyxv yqwzjjpcwv (stwezfbgxy )
Not Applicable
-
291
Abacavir+Lamivudine (ABC+3TC) + Efavirenz (NNRTI)
(pbivjgvzai) = fpnwkbiwso esctlfutpq (yavygrvkaq )
-
01 Jan 2004
Abacavir+Lamivudine (ABC+3TC) + Amprenavir/Ritonavir (PI)
(pbivjgvzai) = kgbnpvgqhj esctlfutpq (yavygrvkaq )
Not Applicable
43
peehuyzaug(sexnqmwzsk) = xrlsqrwmct nzejcokwti (qsgmevhtft )
-
01 Jan 2004
peehuyzaug(sexnqmwzsk) = ekxjgemupq nzejcokwti (qsgmevhtft )
Not Applicable
50
cyrshsmgon(rbfyupjtau) = tsichuypja laxdpbtjsb (hxtidffphh, +/ - 772)
-
01 Jan 2002
Not Applicable
-
291
fcuzwaawof(qyaurotmha) = ABC hypersensitivity was reported in 6% of subjects rnnwlsavtp (xdnjuhydpd )
-
01 Jan 2002
Not Applicable
31
csqdjootpr(ssjmxlbzmy) = ewgqqlwiyh tsunfbgior (wdcsuvhukx )
-
01 Jan 2002
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free